Clinical trial
Exploring the Utility of a Novel BRAF Test in Patients With Melanoma
NCT01840527 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring the Utility of a Novel BRAF Test in Patients With Melanoma
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- September 30, 2022
- Enrollment
- 220 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.